Racanelli, Vito
 Distribuzione geografica
Continente #
EU - Europa 406
AS - Asia 99
NA - Nord America 38
Totale 543
Nazione #
DE - Germania 207
IT - Italia 152
SG - Singapore 87
US - Stati Uniti d'America 38
CN - Cina 12
GB - Regno Unito 10
SE - Svezia 10
IE - Irlanda 9
FI - Finlandia 8
RU - Federazione Russa 6
RS - Serbia 2
AT - Austria 1
FR - Francia 1
Totale 543
Città #
Trento 98
Toenisvorst 49
Uhlingen-Birkendorf 31
Rome 17
Lavis 16
New York 15
Dublin 9
Lappeenranta 5
Bassano del Grappa 4
Helsinki 3
Kent 3
Los Angeles 3
Marzabotto 3
Padova 3
Southwark 3
Wandsworth 3
Ashburn 2
Bari 2
Beijing 2
Council Bluffs 2
Kilburn 2
Palermo 2
Pomarolo 2
Shanghai 2
Shenzhen 2
Smederevo 2
Terre Haute 2
Umeå 2
Vicenza 2
Casale Corte Cerro 1
Cernusco sul Naviglio 1
Dallas 1
Gatchina 1
Munich 1
Nanto 1
Nuremberg 1
Pasadena 1
Perm 1
Prescot 1
Santa Clara 1
Singapore 1
St Petersburg 1
Vienna 1
Voronezh 1
Zhongshan 1
Totale 307
Nome #
Early and Late Response and Glucocorticoid-Sparing Effect of Belimumab in Patients with Systemic Lupus Erythematosus with Joint and Skin Manifestations: Results from the Belimumab in Real Life Setting Study—Joint and Skin (BeRLiSS-JS) 211
Adipose failure through adipocyte overload and autoimmunity 20
Immune-Related Adverse Events Due to Cancer Immunotherapy: Immune Mechanisms and Clinical Manifestations 15
Corrigendum: Cancer survivorship at heart: a multidisciplinary cardio-oncology roadmap for healthcare professionals 12
Impact of belimumab therapy on the quality of life in patients with systemic lupus erythematosus: A cohort study 12
Predicting Factors of Worse Prognosis in COVID-19: Results from a Cross-sectional Study on 52 Inpatients Admitted to the Internal Medicine Department 11
The emerging role of noncoding RNAs in systemic lupus erythematosus: new insights into the master regulators of disease pathogenesis 11
Early Disease and Low Baseline Damage as Predictors of Response to Belimumab in Patients With Systemic Lupus Erythematosus in a Real-Life Setting 10
Clinical Significance of Polymorphisms in Immune Response Genes in Hepatitis C-Related Hepatocellular Carcinoma 10
Arginase 1 (Arg1) as an Up-Regulated Gene in COVID-19 Patients: A Promising Marker in COVID-19 Immunopathy 9
Effect of thyroidectomy on circulating angiogenic cytokines in papillary thyroid carcinoma and benign goiter: Potential for new biomarkers? 9
Anti-COVID-19 Vaccination in Patients with Autoimmune-Autoinflammatory Disorders and Primary/Secondary Immunodeficiencies: The Position of the Task Force on Behalf of the Italian Immunological Societies 9
Drug resistance in multiple myeloma: Soldiers and weapons in the bone marrow niche 9
Cutaneous polyarteritis nodosa and pulmonary arterial hypertension: An unexpected liaison. A case report 8
HB-EGF–EGFR Signaling in Bone Marrow Endothelial Cells Mediates Angiogenesis Associated with Multiple Myeloma 8
Actors on the Scene: Immune Cells in the Myeloma Niche 8
A scoping review on the potentiality of PD-L1-inhibiting microRNAs in treating colorectal cancer: Toward single-cell sequencing-guided biocompatible-based delivery 7
Right Heart Changes Impact on Clinical Phenotype of Amyloid Cardiac Involvement: A Single Centre Study 7
Single-cell RNA sequencing uncovers heterogeneous transcriptional signatures in tumor-infiltrated dendritic cells in prostate cancer 7
SARS-CoV-2 infection complicated by inflammatory syndrome. Could high-dose human immunoglobulin for intravenous use (IVIG) be beneficial? 7
Electrocardiographic Pathological Findings Caused by the SARS-CoV-2 Virus Infection: Evidence from a Retrospective Multicenter International Cohort Longitudinal Pilot Study of 548 Subjects 7
A Systematic Review on the Therapeutic Potentiality of PD-L1-Inhibiting MicroRNAs for Triple-Negative Breast Cancer: Toward Single-Cell Sequencing-Guided Biomimetic Delivery 7
Cytotoxic t-lymphocyte antigen-4 in colorectal cancer: Another therapeutic side of capecitabine 7
Immune Checkpoint Inhibitor-Related Myositis: From Biology to Bedside 7
Risk of acute arterial and venous thromboembolic events in Eosinophilic Granulomatosis with Polyangiitis (Churg-Strauss syndrome) 7
Deciphering the immune landscape of head and neck squamous cell carcinoma: A single-cell transcriptomic analysis of regulatory T cell responses to PD-1 blockade therapy 7
Cancer survivorship at heart: a multidisciplinary cardio-oncology roadmap for healthcare professionals 7
Impact of Antigen Presentation Mechanisms on Immune Response in Autoimmune Hepatitis 7
COVID-19 and the Endocrine System: A Comprehensive Review on the Theme 7
Editorial: Targeting antigen processing and presentation in autoimmune and autoinflammatory disorders 6
Exploiting systems biology to investigate the gene modules and drugs in ovarian cancer: A hypothesis based on the weighted gene co-expression network analysis 6
PDCD1 and IFNL4 genetic variants and risk of developing hepatitis C virus-related diseases 6
Concurrent chromothripsis events in a case of TP53 depleted acute myeloid leukemia with myelodysplasia-related changes 6
Early administration of tofacitinib in COVID ‐19 pneumonitis: An open randomised controlled trial 6
Pemphigus and mucous membrane pemphigoid: An update from diagnosis to therapy 6
Homotypic and Heterotypic Activation of the Notch Pathway in Multiple Myeloma–Enhanced Angiogenesis: A Novel Therapeutic Target? 6
Spotlight on Cardiovascular Scoring Systems in Covid-19: Severity Correlations in Real-world Setting 6
Sars-cov-2 inflammatory syndrome. Clinical features and rationale for immunological treatment 6
Immune escape of multiple myeloma cells results from low miR29b and the ensuing epigenetic silencing of proteasome genes 6
Epstein–Barr Virus in Salivary Samples from Systemic Lupus Erythematosus Patients with Oral Lesions 6
Tumor necrosis factor‑α in systemic lupus erythematosus: Structure, function and therapeutic implications (Review) 6
Non-Classical HLA Class 1b and Hepatocellular Carcinoma 6
Antibiotics or No Antibiotics, That Is the Question: An Update on Efficient and Effective Use of Antibiotics in Dental Practice 6
Carcinogenesis and Metastasis in Liver: Cell Physiological Basis 6
Bone marrow fibroblasts overexpress miR-27b and miR-214 in step with multiple myeloma progression, dependent on tumour cell-derived exosomes 6
CT pulmonary angiography appropriateness in a single emergency department: does the use of revised Geneva score matter? 6
Weighted Gene Co-Expression Network Analysis Combined with Machine Learning Validation to Identify Key Modules and Hub Genes Associated with SARS-CoV-2 Infection 6
Classic pyoderma gangrenosum 6
Application of average volume assured pressure support (AVAPS) and ultrasound assessment in COVID-19 infection: real-life observation 6
A HGF/cMET autocrine loop is operative in multiple myeloma bone marrow endothelial cells and may represent a novel therapeutic target 5
Corona Virus Disease 19 (CoViD-19) impact on cardiovascular disease in a non-CoViD-19 emergency setting 5
High-Risk Multiple Myeloma: Integrated Clinical and Omics Approach Dissects the Neoplastic Clone and the Tumor Microenvironment 5
Galectin-3 and neutrophil-to-lymphocyte ratio are indicative of heart remodelling and disease severity in patients with obstructive sleep apnoea 5
Anti-angiogenesis and Immunotherapy: Novel Paradigms to Envision Tailored Approaches in Renal Cell-Carcinoma 5
VASCULITI NON ATEROSCLEROTICHE DI INTERESSE CHIRURGICO 5
The Role of Hemoglobin Subunit Delta in the Immunopathy of Multiple Sclerosis: Mitochondria Matters 5
Cardiotoxicity Induced by Immune Checkpoint Inhibitors: What a Cardio-Oncology Team Should Know and Do 5
The worldwide impact of COVID-19 on cancer care: A meta-analysis of surveys published after the first wave of the pandemic 5
MEPOLIZUMAB FOR EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS (EGPA): A RETROSPECTIVE REAL-WORLD EUROPEAN STUDY ON 142 PATIENTS 5
BL1391: an established cell line from a human malignant peripheral nerve sheath tumor with unique genomic features 5
T-cell regulation by CD4 regulatory T cells during hepatitis B and C virus infections: facts and controversies 5
From Melanoma Development to RNA-Modified Dendritic Cell Vaccines: Highlighting the Lessons From the Past 5
Unraveling the Role of Peroxisome Proliferator-Activated Receptor β/Δ (PPAR β/Δ) in Angiogenesis Associated with Multiple Myeloma 5
Regulation of ctla-4 and pd-l1 expression in relapsing-remitting multiple sclerosis patients after treatment with fingolimod, ifnβ-1α, glatiramer acetate, and dimethyl fumarate drugs 5
Alterations in the antigen processing-presenting machinery of transformed plasma cells are associated with reduced recognition by CD8+ T cells and characterize the progression of MGUS to multiple myeloma 5
Identification and monitoring of Copy Number Variants (CNV) in monoclonal gammopathy 5
EARLY ECHOCARDIOGRAPHIC DETECTION OF LEFT VENTRICULAR DIASTOLIC DYSFUNCTION IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS ASYMPTOMATIC FOR CARDIOVASCULAR DISEASE 5
The latest findings of PD-1/PD-L1 inhibitor application in gynecologic cancers 4
The Role of V-Domain Ig Suppressor of T Cell Activation (VISTA) in Cancer Therapy: Lessons Learned and the Road Ahead 4
Endothelial cells in tumor microenvironment: insights and perspectives 4
Halting the vicious cycle within the multiple myeloma ecosystem: blocking JAM-A on bone marrow endothelial cells restores the angiogenic homeostasis and suppresses tumor progression 4
Long-term follow up of patients with acute hepatitis C and spontaneous resolution 4
Bortezomib Treatment Modulates Autophagy in Multiple Myeloma 4
The expression pattern of VISTA in the PBMCs of relapsing-remitting multiple sclerosis patients: A single-cell RNA sequencing-based study 4
The Evolving Role of Immune Checkpoint Inhibitors in Hepatocellular Carcinoma Treatment 4
Combination of Ipilimumab and Nivolumab in Cancers: From Clinical Practice to Ongoing Clinical Trials 4
Infectivity of donations from eclipse and ramp-up stages of HCV infection in chimpanzees 4
Idiopathic and connective tissue disease-associated pulmonary arterial hypertension (PAH): Similarities, differences and the role of autoimmunity 4
Anti-VEGF Drugs in the Treatment of Multiple Myeloma Patients 4
Hepatocellular Carcinoma Intrinsic Cell Death Regulates Immune Response and Prognosis 4
Lupus vasculitis: An overview 4
INTERACTION OF JUNCTIONAL ADHESION MOLECULES IN THE BONE MARROW-NICHE: MICE MODEL AND CLINICAL IMPACT FOR MULTIPLE MYELOMA PATIENTS 3
Pancreatic cancer signaling pathways, genetic alterations, and tumor microenvironment: The barriers affecting the method of treatment 3
MicroRNAs-Based Nano-Strategies as New Therapeutic Approach in Multiple Myeloma to Overcome Disease Progression and Drug Resistance 3
Early echocardiographic detection of left ventricular diastolic dysfunction in patients with systemic lupus erythematosus asymptomatic for cardiovascular disease 3
Second-line treatments for Advanced Hepatocellular Carcinoma: A Systematic Review and Bayesian Network Meta-analysis 3
Rheumatic disorders as paraneoplastic syndromes 3
Lenalidomide arrests cell cycle and modulates PD1-dependent downstream mTOR intracellular signals in melanoma cells 3
Systemic Lupus Erythematosus therapy: new possibilities since 50 years 3
Bone marrow endothelial cells of patients with multiple myeloma: antigen presenting functions and T cell regulation 3
Short-Term Variations in Neutrophil-to-Lymphocyte and Urea-to-Creatinine Ratios Anticipate Intensive Care Unit Admission of COVID-19 Patients in the Emergency Department 3
In vitro proliferation of naive B cells and memory B cells: different profiles from healthy and HCV-infected individuals 3
Neutrophil Extracellular Traps (NETs) and Damage-Associated Molecular Patterns (DAMPs): Two Potential Targets for COVID-19 Treatment 3
18F-FDG PET/CT: a review of diagnostic and prognostic features in multiple myeloma and related disorders 3
Prognostic role of neoplastic markers in Takotsubo syndrome 3
Alterations in the antigen processing-presenting machinery of transformed plasma cells are associated with reduced recognition by CD8+ T cells and characterize the progression of MGUS to multiple myeloma 3
Myeloma cells act as tolerogenic antigen-presenting cells and induce regulatory T cells in vitro 3
Common variable immunodeficiency and gastric malignancies 2
Bone marrow endothelial cells sustain a tumor-specific CD8+ T cell subset with suppressive function in myeloma patients 2
HCV-NS3 and IgG-Fc crossreactive IgM in patients with type II mixed cryoglobulinemia and B-cell clonal proliferations RID E-7324-2011 2
Totale 783
Categoria #
all - tutte 9.706
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 165
Totale 9.871


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2023/2024908 0 167 89 211 9 42 136 85 58 58 53 0
Totale 908